Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Reyka G. Jayasinghe, Song Cao, Qingsong Gao, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 270-281.e3
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sánchez-Vega, Marco Mina, Joshua Armenia, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 321-337.e10
Open Access | Times Cited: 2677
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 565
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 305-320.e10
Open Access | Times Cited: 351
Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang, Barbara Schrörs, Martin Löwer, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 261-282
Open Access | Times Cited: 341
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko, Steven A. Rosenberg
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 454-472
Open Access | Times Cited: 319
Aberrant RNA Splicing in Cancer
Luisa F. Escobar‐Hoyos, Katherine Knorr, Omar Abdel‐Wahab
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 167-185
Open Access | Times Cited: 284
Alternative tumour-specific antigens
Christof C. Smith, Sara R. Selitsky, Shengjie Chai, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 465-478
Open Access | Times Cited: 278
Alternative mRNA splicing in cancer immunotherapy
Luke Frankiw, David Baltimore, Guideng Li
Nature reviews. Immunology (2019) Vol. 19, Iss. 11, pp. 675-687
Closed Access | Times Cited: 223
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
Sydney X. Lu, Emma De Neef, James D. Thomas, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 4032-4047.e31
Open Access | Times Cited: 214
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 200
Comprehensive Study of the Clinical Phenotype of GermlineBAP1Variant-Carrying Families Worldwide
Sebastian Walpole, Antonia L. Pritchard, Colleen M. Cebulla, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 110, Iss. 12, pp. 1328-1341
Open Access | Times Cited: 195
RNA Splicing and Cancer
Eric Wang, Iannis Aifantis
Trends in cancer (2020) Vol. 6, Iss. 8, pp. 631-644
Closed Access | Times Cited: 185
A pan-cancer analysis of synonymous mutations
Yogita Sharma, Milad Miladi, Sandeep Dukare, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 184
Best practices for bioinformatic characterization of neoantigens for clinical utility
Megan M. Richters, Huiming Xia, Katie M. Campbell, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 177
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Sebastian P. Haen, Markus Löffler, Hans‐Georg Rammensee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 595-610
Open Access | Times Cited: 174
Targeting mRNA processing as an anticancer strategy
Joana Desterro, Pedro Bak‐Gordon, Maria Carmo‐Fonseca
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 112-129
Closed Access | Times Cited: 162
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Malgorzata Ewa Rogalska, Claudia Vivori, Juan Valcárcel
Nature Reviews Genetics (2022) Vol. 24, Iss. 4, pp. 251-269
Closed Access | Times Cited: 133
Dysregulation and therapeutic targeting of RNA splicing in cancer
Robert Stanley, Omar Abdel‐Wahab
Nature Cancer (2022) Vol. 3, Iss. 5, pp. 536-546
Open Access | Times Cited: 105
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer
Kelsy C. Cotto, Yang-Yang Feng, Avinash Ramu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 76
RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 17
Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data
Naoko Iida, Ai Okada, Yoshihisa Kobayashi, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Molecular profiling of driver events in metastatic uveal melanoma
Joakim Karlsson, Lisa M. Nilsson, Suman Mitra, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 137
Altered RNA Processing in Cancer Pathogenesis and Therapy
Esther A. Obeng, Connor Stewart, Omar Abdel‐Wahab
Cancer Discovery (2019) Vol. 9, Iss. 11, pp. 1493-1510
Open Access | Times Cited: 126
Page 1 - Next Page

Scroll to top